It is a pharma private limited company based in Dist-Cuttack, Orissa, India, established in 2018.
2018 | Dist-Cuttack, Orissa, India | ActiveAlbirus Pharmaceuticals Private Limited, a active private limited company, was established on 08 September 2018 in Dist-Cuttack, Orissa, India. Engaging in pharmaceutical retailers & distributors within the construction sector, it holds CIN: U51909OR2018PTC029428. Registered under ROC Roc Cuttack. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.10 M.
Its leadership includes Upasana Sinha (Director), Amit Kumar Sinha (Director). Past directors included Uma Shankar Mishra, Man Kumar Das, Ashis Sinha. It holds ₹1.90 M open charges and no settled loans. Its latest AGM occurred on 15 November 2021, with the balance sheet filed on 31 March 2021. It is based at Plot No-1854, K N-1250,At-Kathagada Sahi Po-Buxibazar, Ps-Purighat, Cuttack Sadar, Dist-Cuttack, Orissa, 753001.
U51909OR2018PTC029428
029428
08 September 2018
₹1.00 M
₹0.10 M
Roc Cuttack
Unlisted
Active
Explore comprehensive insights into Albirus Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Upasana Sinha | Director | 16 Jan 2024 | Current |
| Amit Kumar Sinha | Director | 08 Sep 2018 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 23 Oct 2021 | Past |
| Pramod Abcsdd | Director | 22 Mar 2022 | Past |
| Pramod Abcsdd | Managing Director | 18 Jan 2024 | Past |
| Pramod Abcsdd | Director | 11 Oct 2018 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Albirus Pharmaceuticals Private Limited, for the financial year ended 2020, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 150.53% increase in profit. The company's net worth Soared by an impressive increase of 25.76%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2020, Albirus Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹1,900,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 06 Apr 2024 | Canara Bank | ₹1.00 M | Open |
| 30 Aug 2021 | Others | ₹0.90 M | Open |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Albirus Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Albirus Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Albirus Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity A charge with Canara Bank amounted to Rs. 1.00 M with Charge ID 100906103 was registered on 06 Apr 2024. was completed.
Upasana Sinha was appointed as a Director was appointed as a Director on 16 Jan 2024 & has been associated with this company since 1 year 11 months . was recorded as a recent event.
The activity Albirus Pharmaceuticals Private Limited last Annual general meeting of members was held on 15 Nov 2021 as per latest MCA records. was completed.
Progress on A charge with Others amounted to Rs. 0.90 M with Charge ID 100485622 was registered on 30 Aug 2021. was documented.
Progress on Albirus Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2021 with Roc Cuttack. was documented.
Progress on Amit Kumar Sinha was appointed as a Director was appointed as a Director on 08 Sep 2018 & has been associated with this company since 7 years 3 months . was documented.
The CIN of Albirus Pharmaceuticals Private Limited is U51909OR2018PTC029428.
Albirus Pharmaceuticals Private Limited is headquartered at Plot No-1854, K N-1250,At-Kathagada Sahi Po-Buxibazar, Ps-Purighat, Cuttack Sadar, Dist-Cuttack, Orissa, 753001.
Albirus Pharmaceuticals Private Limited was incorporated on 08 September 2018.
The current directors of Albirus Pharmaceuticals Private Limited are
The primary industry of Albirus Pharmaceuticals Private Limited is Construction.
Albirus Pharmaceuticals Private Limited is unlisted.
The authorized capital of Albirus Pharmaceuticals Private Limited is ₹1.00 M, and the paid-up capital is ₹0.10 M.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX